Cargando…
Impact of Center-related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric-inspired Protocols
Autores principales: | Barba, Pere, Morgades, Mireia, Montesinos, Pau, Gonzalez-Campos, Jose, Torrent, Anna, Gil, Cristina, Bernal, Teresa, Tormo, Mar, Mercadal, Santiago, Novoa, Sandra, García-Cadenas, Irene, de Llano, M. Paz Queipo, Cervera, Marta, Coll, Rosa, Bermudez, Arancha, Amigo, M. Luz, Monsalvo, Silvia, Esteve, Jordi, Garcia-Boyero, Raimundo, Novo, Andres, Hernandez Rivas, Jesús Maria, Cladera, Antonia, Martinez-Sanchez, Pilar, Serrano, Josefina, Artola, Maria Teresa, Soria, Beatriz, Abella, Eugenia, Vall-Llovera, Ferran, Bergua, Juan, Herrera, Pilar, Barrios, Daniel, Ribera, Josep Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794204/ https://www.ncbi.nlm.nih.gov/pubmed/36583094 http://dx.doi.org/10.1097/HS9.0000000000000810 |
Ejemplares similares
-
P1702: IMPACT OF CENTER CHARACTERISTICS AND MACROECONOMIC FACTORS ON THE OUTCOME OF ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH PEDIATRIC-INSPIRED PROTOCOLS
por: Barba, P., et al.
Publicado: (2022) -
A pediatric regimen for adolescents and young adults with Philadelphia chromosome‐negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial
por: Ribera, Josep‐Maria, et al.
Publicado: (2020) -
Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials
por: González-Gil, Celia, et al.
Publicado: (2022) -
P1147: FEASIBILITY AND OUTCOME AFTER DOSE REDUCTION OF IMMUNOCHEMOTHERAPY IN YOUNG ADULTS WITH BURKITT LYMPHOMA AND LEUKEMIA. RESULTS OF THE BURKIMAB14 TRIAL
por: Maria Ribera, Josep, et al.
Publicado: (2023) -
Ponatinib, chemotherapy, and transplant in adults with Philadelphia chromosome–positive acute lymphoblastic leukemia
por: Ribera, Josep-Maria, et al.
Publicado: (2022)